As women age, there are significant hormonal changes that can impact health and quality of life. Hormone replacement therapy (HRT) has long been a topic of discussion in women’s health, particularly for perimenopausal, menopausal, and postmenopausal women. Many women experience hot flashes, mood swings, and other discomforts during this natural phase of life. Women during this life stage are at increased risk of heart disease, cancer, and osteoporosis. We know that estrogen decreases many of those risks.
In the wake of the Women’s Health Initiative (WHI) study in 2002, concerns surrounding hormone therapy (HT) in women, especially those over 65, have persisted. However, a new study published in Menopause, the journal of The Menopause Society, challenges these fears, emphasizing the importance of considering the type, route, and dose of hormone therapy. They performed a comprehensive analysis of 10 million Medicare women(over age 65) spanning 2007 to 2020.
One of the study’s strengths lies in its examination of various hormone therapy formulations, doses, and administration routes, a previously unexplored area. The results are encouraging: estrogen in women beyond 65 was associated with reduced risks of all cause of mortality, cancer, heart disease, osteoporosis and other conditions.
If you’re struggling with menopausal symptoms, know that you have options. Hormone therapy, when tailored to your individual needs and risk factors, can offer significant relief and is safe. Don’t let misconceptions hold you back from exploring and no need to stop if its working well. If you’re interested in learning more about hormone therapy and its potential benefits, reach out to Dr. Karen Toubi for more information. Her expertise in menopause care and sexual medicine can provide valuable insights and guidance on how hormone therapy may benefit you or a loved one.
